IL-12 is a proinflammatory cytokine with strong tumor inhibitory activity, that not only stimulates T cells to secrete IFN-γ to enhance the cytotoxicity of CAR-T cells, but also limits the activation of regulatory T (Treg) cells, reshaping the TME in an IFN-γ-dependent manner (48). This evidence concerns the gene IFNG and neoplasm.